Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV-Infected Pediatric Patients

NCT00017992 is registered in ClinicalTrials.gov with Triangle Pharmaceuticals as lead sponsor.

NCT NCT00017992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00017992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV-Infected Pediatric Patients
Lead sponsor
Triangle Pharmaceuticals
Phase
Phase 2
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
100
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections